Hemapheresis Flashcards

1
Q

How much will 1 volume exchange remove?

A

2/3 of substance are removed if large amounts are not in extravascular space.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is ECP or extracorporeal photopheresis?

A

Photopheresis separates lymphocytes from whole blood, exposes these cells to ultraviolet light in the presence of a photoactive agent and returns them to the patient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What diseases is ECP used for?

A

Used in cutaneous T-Cell leukemia, GVHD and solid organ rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is LDL apheresis?

A

The specific removal of the cholesterol-containing particle low-density lipoproteins (LDL) from the blood stream. Used in patients with severe hyper-cholesterolemia where diet and medications are ineffective.

Heparin used for anticoagulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the principle of ECP?

A

Buffy coat is removed and treated with 8-Methoxy Psoralen that crosslinks DNA in WBC causing cell death
ECP has complex immunomodulatory effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How much of IgG antibodies are in intravascular space?

A

45%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How much of IgM antibodies are in intravascular space?

A

76%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How much fibrinogen is in intravascular space?

A

80%

*Fibrinogen will decrease 60-80% per 1 volume exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the anticoagulant used?

A

Citrate. Binds to free calcium to prevent coagulation
Can causes hypocalcemia

(except LDL-heparin; also may be used for patients with risk of hypocalcemia- small children, renal failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the adverse effects of Citrate?

A

Perioral and/or peripheral paresthesia
Nausea, vomiting, lightheadedness, shivering, twitching
Tetany = rare
Vasovagal reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a vasovagal reaction?

A

Most common. Pallor, diaphoresis, hypotension, and/or bradycardia – mild reactions
Nausea, vomiting, syncope and/or convulsions - severe reactions
Slow pulse rate is a useful sign differentiating vasovagal from hypovolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

desired catheter specifications

A

double lumen, staggered port, large bore lumen catheter of minimum length and sufficient firmness with biocompatibility/resistance to infection
17 gauge needle for withdraw and 18 gauge catheter for return of blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is immunoadsorption?

A

Prosorba column – single-use; contains inert silica particles coated with staphylococcal Protein A.
Binds Fc portion of IgG and IgG that is complexed in circulating immune complexes
NOT available in US

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Rheopheresis?

A

Used for treatment of dry age-related macular degeneration (AMD).
Composed of a filter to separate plasma from RBCs. Plasma is then run through a membrane filter that eliminates high molecular weight proteins. The filtered plasma is recombined with the patient’s RBCs and returned.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Guilain-Barre (acute inflammatory demyelinating polyradiculoneuropathy)

A

TPE Category I

QOD (5-6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ANCA associated rapidly progressive glomerulonephritis

A

TPE Category I

QD or QOD (6-9)

17
Q

Chronic inflammatory demyelinating polyradiculoneuropathy

A

TPE Category I

2-3/week

18
Q

Cryoglobulinemia

A

TPE Category II

QOD (3-8)

19
Q

Focal segmental glomerulosclerosis

A

TPE Category I

1-3/week

20
Q

HELLP

A

TPE Category III

21
Q

Hyperviscosity in monoclonal gammopathies

A

TPE Category I

QD (1-3)

22
Q

Immune thrombocytopenia

A

TPE Category III

QOD(6)

23
Q

Myasthenia gravis

A

TPE Category I

24
Q

Thrombotic thrombocytopenic purpura

A

TPE Category I

QD variable length based on patient response monitored by platelet count

25
Q

Wilson disease

A

TPE Category I

26
Q

Antibody mediated rejection of solid organ

A

TPE Category 1- non-ABO

TPE Category 2- ABO

27
Q

Hereditary Hemochromatosis

A

Erythrocytapheresis Category I

every 2-4 weeks

28
Q

Polycythemia Vera

A

Erythrocytapheresis Category I

29
Q

Sickle cell disease

A

Red cell exchange Category I

30
Q

Babesios (severe)

A

Red cell exchange Category II

31
Q

Thrombocytosis

A

Thrombocytapheresis Category II

32
Q

Cutaneous T-cell Lymphoma

A

Photopheresis Category I

Every 2-4 weeks (5-6 months)

33
Q

Graft vs Host

A

Photopheresis Category II

34
Q

Cardiac/Lung transplant rejection

A

Photopheresis Category II

35
Q

age related macular degeneration

A

Rheopheresis Category I

8-10 over 8-21 weeks

36
Q

familial hypercholesterolemia

A
lipid apheresis Category I (homozygotes)
Category II (heterozygotes)